GSTfor 5'-TCTCTCGGATCCCTTCATCTGTTAAGTAAGAATTGG-3' and 1-GSTrev 5'-TCTCTCGGATCCAAGCTTCAGTCTGCCTC-3' (59˚C annealing), and mtRF1a (nt 124 to 1534) was amplified with primers 1a-GSTfor 5'-TCTCTCGGATCCCTGGAGGAGCTGTTCG-3' and 1a-GSTrev 5'-TCTCTCGGATCCTGAGGAGCTCCTTAGG-3' (52˚C). Amplicons were digested and fused in-frame downstream of GST to facilitate purification.
Finally cDNAs containing the entire ORFs were amplified using Not1-1for 5'-CTCTCTGCGGCCGCTGCTGAGATGAATCGTCAC-3'/Not1-1rev 5'-CTCTCTGCGGCCGCGATTTCCAAGCTTCAGTCTG-3' or Not1-1afor 5'-CTCTCTGCGGCCGCATCTCGGACTAAGGATGC-3'/Not1-1arev 5'-CTCTCTGCGGCCGCAGAGTAAGGGTACTTTCACC-3' primer pairs for mtRF1 and mtRF1a respectively. NotI sites are underlined and restriction fragments from both cDNAs were subcloned in forward orientation into the NotI sites of the S. cerevisiae URA3 expression vector pFL61 (Minet et al., 1992) and of the S. pombe ura4 expression vector pTG1754 (a gift from Transgene, (Chiron et al., 2005) ). Both vectors contain strong constitutive promoters.
Yeast growth conditions, plasmid and general strain constructions and complementation assays
The S. cerevisiae MRF1 ORF was PCR amplified from genomic DNA and cloned into pFL61-BEB (a derivative of pFL61 containing a BamHI site). The S. cerevisiae MATα ∆mrf1::Kan R haploid strain Y14510 was ordered from Euroscarf, depleted of mtDNA by growth on ethidium bromide containing medium, and crossed to a wild type strain containing an intron-less mitochondrial genome (CW252/A, a MATa version of CW252, (Saint-Georges et al., 2002) . The resulting heterozygous ∆mrf1 diploid KV2 and a control wild type diploid were transformed with the control vector or plasmids producing the human or yeast proteins. Diploids were sporulated and tetrads dissected (Sanger micromanipulator) on minimal medium lacking uracil to maintain the plasmids. For biochemical studies isogenic strains were generated by transforming the rho° versions of Y14510 (∆mrf1Sc) or BY4742 (wt) with empty vector or one producing either S. cerevisiae Mrf1 or human mtRF1a, and then introducing the intron-less mtDNA through cytoduction with the karyogamy deficient strain JC8/252.
Tissue culture
Human HeLa, HepG2 and HEK293 cells were cultured (37˚C, humidified 5% CO 2 ) in Eagle's modified essential medium (Sigma) supplemented with 10% (v/v) foetal calf serum, non-essential amino acids and 2 mM L-glutamine. For growth on respiratory substrates cells were cultured in glucose free DMEM (Gibco) supplemented with 0.9 mg/ml galactose, 1 mM sodium pyruvate, 10% (v/v) foetal calf serum, non-essential amino acids and 2 mM L-glutamine.
Transient transfection of HeLa cells, microscopy and image capture
HeLa cells were grown to 50% confluency on coverslips and transfected with vectors expressing the GFP fusion constructs (1 µg) using Superfect (Qiagen) as recommended.
Cells were cultured for a further 24 h prior to incubation with Mitotracker Red CM-H2XRos
(1 µM final, Invitrogen). After brief fixation (4% paraformaldehyde in PBS, 15 min at room temperature), cells were mounted in Vectashield (H-1500 Vector Laboratories Inc) and visualised by fluorescence microscopy using a Leica (Nussloch Germany) DMRA. Images were recorded as a Z-series (0.5 µm slices) using a cooled CCD camera and imaging system (Spot -II Diagnostics Instruments, Sterling Heights MI, USA). residues for purified mtRF1 and 32 residues for mtRF1a. E.coli RF1 was overexpressed and purified from strain BL21 pLysS following the protocol described in (Tate and Caskey, 1990 ).
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In vitro translation termination assay
This was performed essentially as described in (Caskey et al., 1971; Tate and Caskey, 1990 ) with complexes simulating the state of the ribosome at the terminal stage of protein synthesis being generated to test release activity of proteins with specific RNA oligomers.
Modifications to the published protocol included increasing the concentrations of putative stop codons from 250 to 400 pmol, release factor from 5 to 50 pmol, and time of incubation to 40 min.
70S ribosomes, amino-acyl tRNA synthetase and formylating activities were all isolated from purchased MRE 600 paste (UAB Fermentation facility, Birmingham, Alabama USA).
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Cell preparations and western analysis
Lysate was prepared by pelleting human cells from 75 cm 2 flasks and resuspending in 150 µl of lysis buffer (50mM Tris-HCl pH 7.5, 130mM NaCl, 2mM MgCl 2 , 1% Nonidet P-40, 1 mM PMSF and Roche EDTA protease inhibitor cocktail). This was vortexed briefly, spun at 1500g for 5 min at 4˚C and the supernatant retained.
Human mitochondrial fractions were prepared from cell pellets resuspended in 0.6 M mannitol, 10 mM Tris-HCl pH7.4, 1 mM EGTA, 0.1% BSA and hand homogenised by 15 passes in a Teflon:glass tissue grinder. Following centrifugation at 600g the supernatant was retained and the pellet was re-homogenised and spun as before. The combined supernatants were cleared at 600g and then the crude mitochondria pelleted at 15kg. These were washed in buffer lacking BSA and frozen in liquid nitrogen until required. S. cerevisiae and S. pombe mitochondria were purified from cells grown in minimal galactose (S. cerevisiae) or glucose (S. pombe) media lacking uracil as described in (Wallis et al., 1994) and (Chiron et al., 2007) respectively, except that protease inhibitors tablets (Roche) were added before breaking the protoplast and during all subsequent steps. S. pombe total proteins were extracted as in (Chiron et al. 2005) . Blue native gel electrophoresis was performed as described in (Nijtmans et al., 2002) with the modification that 30 µg protein was loaded per lane and wet transfer as above.
siRNA transfection
Both negative control and mtRF1a specific siRNA duplexes were purchased pre-annealed from Eurogentec. The negative control is a unique sequence that does not match any sequence in the genome. Sense strands for siRNA specific to the mRNA encoding mtRF1a were :-1) GACGCUGCAUGAUCUUGAAdTdT, 2)
CCAUGACUGUAGCAAUAUUdTdT and 3) CGAUGAGAAUGAAGAUUUAdTdT.
HeLa cells in a 35 mm dishes were grown to 20-30% confluency, incubated in 800 µl DMEM (D6429, Sigma) supplemented with 10% FCS, 50 µg/ml uridine and 1x nonessential amino acid, to which the Oligofectamine (Invitrogen) transfection mix in OptiMEM (Gibco) was added to give a final concentration of 0.2 µM siRNA. Cells were cultured in this medium for 3 days and then either harvested or retransfected for the 6 day time point.
De Novo mitochondrial protein synthesis
HeLa cells were cultured in 35 mm dishes until 70% confluent, then incubated in methionine free medium for 1 h. This medium was replaced with 1 ml labeling medium (methionine/cysteine-free DMEM, 10% dialyzed FBS, emetine 10 µg /ml, and 500 µCi 
Determination of mRNA poly(A) tail length (MPAT)
The additional primers used in this paper to analyse the following transcripts were as follows :-MTCO1, first primer 5'-CATATTCATCGGCGTAAATC-3', nested radiolabelled primer 5'-CAACCCCATGGCCTCCA-3' ; MTCO2, first primer 5'-GGTATACTACGGTCAATG-3', nested radiolabelled primer 5'-TATAGCACCCCCTCTACCCC-3' ; ND1 first primer 5'-TAAACACCCTCACCACTACA-3', nested radiolabelled primer 5'-TACAATCTCCAGCATTCCC-3' ; ND3 first primer 5'-CCGCCCGCGTCCCTTTC-3', nested radiolabelled primer 5'-GACTACAAAAAGGATTAGACT-3'. An annealing temperature of 54˚C was used for all reactions except with MTCO2 first primer, which was 50˚C. Release activity assays were programmed independently with mtRF1a or E.coli RF1. The addition of human mtRF1 did not affect the substrate release profile when the ribosomal A site was occupied by UAG or UAA. SEM bars were calculated from over six independent experiments.
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